Cite

HARVARD Citation

    Beland, B. et al. (2023). Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti‐muscle specific kinase antibodies. Muscle & nerve. 67 (2), pp. 154-157. [Online]. 
  
Back to record